lecture 1 Flashcards

1
Q

antimicrobial

A

Any chemicals which kill or inhibit microbial growth in or on a body surface (Fungal, viral, bacteria…)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

antibacterial

A

chemical that specifically target bacteria, killing or inhibiting its growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

state the sources of antibiotics

A

microorganisms like penicillin, synthesis like chloramphenicol, and semi-synthesis which is the most common, like amoxicillin.
most antibiotics work only on actively growing bacteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are latent infections

A

where the bacteria are present but not actively growing – so are in a dormant / persister state are hard to treat-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

explain bactericidal, bacteriostatic, and selective toxicity

A

1-kill bacteria
2-slow down or stall bacterial growth
3-selectively kills or inhibits the target organism, whilst causing no or minimal harm to the host

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

explain the ideal properties and activities of antibacterials.

A

specific, selective, bactericidal, minimal emergence of resistance to the drug, along with pharmacological activities
Specific: the ability of a drug/chemical agent to interact with a defined target
Selective: selectively kills or inhibits the target organism, whilst causing no or minimal harm to the host as less selectivity means more adverse effects.
Pharmacological activities
- Non toxic to host
- Long plasma half life
- Good tissue distribution
- Low plasma protein binding
- Oral & parenteral
- No interference with other drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

name antibacterial classification based on cellular targets

A

cell wall- major target and selective, bactericidal
protein synthesis- many drugs, exploit the differences between prokaryotic and eukaryotic ribosomes, selective, mainly bacteriostatic
nucleic acid- may drugs, different cellular machinery, selective, mainly bactericidal
cell membrane- few drugs as cell membranes are highly similar. few targets selective for bateria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

name the classes of inhibitors of cell wall synthesis

A

Beta lactams-Penicillins, cephalosporins, carbapenems, monobactams
glycopeptides-Vancomycin, teicoplanin
Fosfomycin
cycloserine
bacitracin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

explain peptidoglycan and where it gets its strentgh and rigidity

A

the peptidoglycan layer it is broadly similar in Gram positive and Gram negative bacteria

It’s made up of a glycan (or polysaccharide) backbone, which has short peptide side chains.

The polyscaccharide part is made up of two different glycans-
N-acetyl-glucosamine or NAG and
N-acetyl-muramic acid or NAM –
And these NAG, and NAM residues alternate along the chain and are linked together by strong glycosidic bonds.
This give the structure strength in the Horizontol direction
(These N.A.G. and N.A.M are also known as amino sugars )
Attached to each molecule of N-acetyl muramic acid is a short peptide side chain (a chain of amino acids) –
The peptide side chains then cross link to a neighbouring peptide on an adjacent peptidoglycan. This gives a strong bond in the vertical direction

The peptide side chain is shown here in the final structure as 4 amino acids, but actually it starts off as 5 amino acids, and the terminal amino acid is removed during the crosslinking step,

The two types of bond: the glycosidic bonds and the crosslinking between peptides are what gives the cell wall its rigidity in the horizontal and vertical directions, and help create the strong mesh like structure.
If you break down either the vertical rigidity or horizontal rigidity then you destroy the cell.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

peptidoglycan biosynthesis

A

dont need to learn but learn if you have time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Beta lactams

A

all have beta lactam ring. the differneces are in the r groups( the ring attached to beta lactam and the side chains)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

explain beta lactams 3 modes of action.

A

direct: inhibit the crosslinking of the peptide side chains
1-Bind to and inhibit action of transpeptidases usually known as Penicillin Binding Proteins (PBPs) -The drugs directly bind to the Transpeptidases – also known as the Penicillin binding proteins or PBPs which catalyse the crosslinking of the peptide side chains.
This inhibits the enzyme from catalysing the reaction, there is no crosslinking and you lose the rigidity of the cell wall in the vertical direction

Prevents X-linking  prevents stable formation of peptidoglycan  cell lysis

or
2-Get incorporated into peptide side chain
Prevents X-linking  prevents stable formation of peptidoglycan  cell lysis
If you look at their structure it is similar to the last 2 amino acids of the peptide side chain on the peptidoglycan and the drug can be incorporated into that peptide sidechain
this has the same effect –in that if the drug is in this position and not the amino acids
It again inhibits cross linking by the Penicillin binding proteins and effects the rigidity of the cell wall.
incorporation into the peptide side chain is the second direct mode of action.
indirect mode of action: they stimulate enzymes called autolysins inside the bacterial cell, which causes the bacteria to break down their own cell well, which again causes the cells to lyse.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

why do beta lactams work better on gram positive bacteria

A

beta lactams need to interact with PBP, which is an enzyme on the outer membrane, to work. in gram positive bacteria, it is easier as the only obstacle between the PBP and the drug is a meshwork of peptidoglycans which is not a solid barrier. But in gram negative bacteria, it is no as easy, since the drug has to pass through a cell membrane before interacting with the PBPs, which they can only do via porin channels, which only small or hydrophilic structures can pass through( my answer)
Beta Lactams can work in both Gram positive and Gram Negative bacteria- but we have more which can work on the Gram Positive bacteria
Beta Lactams are targeting an enzyme on the outer surface of the bacteria’s cytoplasmic membrane.- they don’t need to enter the cell
In Gram +ve bacteria they just have to penetrate the cell wall – which is a mesh like structure, its’ not a solid barrier – they can easily reach the outer surface of the cytoplasmic membrane and bind to the Penicillin Binding Protein.
For Gram -ve bacteria -to reach their target they first have to pass through the outer membrane – which they can only do by entering through the pores in the membrane- porin channels .
Only smaller hydrophilic antibacterial agents are able to pass through these channels- it is harder for larger molecules/ or hydrophobic to reach their target.
Depending on their precise structure some Beta lactams can pass through these channels and others can’t, and so only some types of beta lactam antibiotic can treat some Gram negative bacteria.
Eg pseudomonas has small porin channels (answer in the slides)
Beta-lactams need to interact with penicillin-binding proteins (PBPs), enzymes located on the outer surface of the cytoplasmic membrane, to exert their effect. In Gram-positive bacteria, the only barrier is the peptidoglycan layer, which is a porous, mesh-like structure. This allows beta-lactams to easily reach PBPs.

In contrast, Gram-negative bacteria have an additional outer membrane. Beta-lactams must pass through porin channels in this membrane to reach PBPs. These channels restrict access based on size and hydrophilicity, making it harder for larger or hydrophobic beta-lactams to penetrate. As a result, only certain beta-lactams, like carbapenems, are effective against some Gram-negative bacteria. For example, Pseudomonas aeruginosa has small porin channels, further limiting drug entry. ( chat gpt answer)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

glycopeptide antibiotics, how do they work?

A

large gram positive specific antibiotic ( because they are very large)
Glycopeptides target cell wall synthesis and again target the peptidoglycans
Vancomycin iworks in 2 ways:

1 Vancomycin binds very tightly to the last 2 amino acids on the peptide sidechain of the peptidoglycan monomer. They are normally 2 alanine residues. (Ala-d- Ala)
This means that again it prevents crosslinking of the peptide sidechains- the pbp enzyme cant bind and can’t cleave the terminal amino acid, so cross linking can’t occur

2 Vancomycin also prevents the peptidoglycan monomer being attached on to the peptidoglycan chain- it inhibits the glycosylase enzyme from working.
And prevents the glycan chain forming. If you remember glycosolases catalyse its addition onto the peptidoglycan structure by the the formation of glycosidic bonds between the sugar residues.
If the Vancomycin, which is a large molecule is attached it is very big and so prevents the glycosylases working

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

inhibitors acting on cell membrane and their example

A

polymyxins-
polymyxin E (Colistin)- fell out of use due to severe nephrotoxicity
Lipopeptides-
daptomycin (Cubicin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

how do polymyxins work?

A

there are polymyxins a to e. all work the same way-> they target lipopolysaccharide of gram -ve bacteria.
lipopolysaccharides are made of lipid a-core-O-antigen.
colistin binds to lipid a->distorts the membrane-> penetrates the cell wall->dirrupts emembrane integrity as a secondary effect-> allows leakage of cytoplasmic contents
Colistin E is reserved for treating drug resistant Gram negative bacteria – where the usual first line antibiotics no longer work –
For example Carbapenem Resistant Enterobacteriaceae. (CRE)

17
Q

explain the classificaation of antibacterials acting on nuecleic acid

A

The Metabolic inhibitors – these inhibit the synthesis of the nucleic acid precursers – sulphonamides, trimethoprim
Prevent DNA replication-DNA replication is essential , and targeting it will kill the bacteria. – fluoroquinolones, like ciprofloxacin and levofloxacin
affect RNA polymerase – if you can’t make RNA , you can’t synthesise proteins- rifamycins like rifampici
target DNA directly – so for example they cause strand breakage- nitroimidazoles like metronidazole

18
Q

how does dna replication work in bacteria

A

DNA replication starts at origin.
dsDNA unwound by helicase to expose template DNA strands.
Unwinding generates supercoils which removed by DNA gyrase (Topoisomerase II)
Zone of unwound DNA called replication fork.
DNA polymerase syntheses complimentary DNA strands at replication fork
Replication is bidirectional
Two replication forks collide at opposite side of chromosome
At this point, 2 circular chromosomes linked together
Topoisomerase IV separates DNA
Chromosomes partitioned into each daughter cell
(Remember in bacteria there is no nucleus or individual chromosomes, the DNA floats in the cytoplasm in one circular loop, and to replicate the bacteria need to make a copy of that loop.)

19
Q

how do fluroquinolones work

A

they bind to and inhibit dna gyrase and/or topoisomerase IV when complexed with bacterial DNA. DNA gyrase removes DNA supercoils ahead of replication fork
topoisomerase IV separates DNA after replication.
This inhibits DNA replication and packaging of dna within the bacterial cell which leads to cell lysis

20
Q

what are the differences and similarities between bacterial and mammalian ribosomes?

A

The process of Protein synthesis is very similar in eukaryotes and prokaryotes, -
prokaryotes synthesise proteins 10 times faster than eukaryotes do.
The bacterial and mammalian ribosomes differ in their structure.
Eg they differ in the sizes of the two sub units. The prokaryotic subunits are smaller: 50s and 30 S compared to the 60S and 40S in mammalian cells.
Within the subunits they differ in their structure for example the sizes of the ribosomal RNA differs. 23s compared to 26S
We can exploit these differences to give us selective drug targets which inhibit bacterial protein synthesis.
bacteria have 50S subunit(23S rRNA, 5S rRNA+ proteins)
and 30S subunits(16S rRNA + proteins) but mammals have 60S subunit(26S rRNA, 5.8S rRNA, 5S rRNA + proteins) and 40S subunit(18S rRNA and proteins)

21
Q

name the classifications of protein sunthesis inhibitors with example

A

We have a large number of protein synthesis inhibitors and different groups target different parts of the ribosome.
Some target the smaller 30S subunit: the Tetracyclines and Aminoglycosides.-.
Some target the 50s Subunit :Chloramphenicol, Macrolides, Streptogamins, and Lincosamides etc
Some bind to the elongation factors they don’t bind directly to the subunits.
Eg Fusidic Acid

21
Q

how does protein synthesis work in bacteria

A

THREE phases of translation:
Initiation
The ribosome assembles around the template mRNA.
The first tRNA is attached at thestart codon.
Elongation
The tRNA transfers an amino acid to the mRNA corresponding to the next codon.
The ribosome then moves (translocates)to the next mRNA codon to continue the process, creating an amino acid chain.
Termination
When a stop codon is reached, the ribosome releases the polypeptide.
https://www.youtube.com/watch?v=Ikq9AcBcohA

22
Q

how do tetracyclines work?

A

tetracyclines( like doxycycline) woek by reversibly binding to the A site on 16S rRNA in 30S subunit which prevents tRNA molecule binding to the mRNA at the acceptor site so no protein synthesis.It binds reversibly so it can only ever be bacteriostatic –

Tetracycline also binds equally effectively to our own ribosomes-
however the bacteria are much more efficient at accumulating it inside their cells, which is why we can use it as a selective drug.
However we should always be aware of side effects when we use tetracycline antibiotics

23
Q

how do aminoglycosides work?

A

The final group of antimicrobials which we’ll look at are another type of protein synthesis inhibitor called the Aminoglycosides- an example is gentamicin ( another one is tobramycin)
These antibiotics are reserved for use in a hospital setting, and are used to treat serious. Infections.
They can cause serious side effects – and a patient receiving gentamicin should undergo threpeutic Dose monitoring

Similary to the tetracyclines the Aminoglycosides also bind to a region in the Acceptor site in the 30S subunit-
However It’s a different site, and they do this irreversibly.
And the effects are bactericidal.

The aminoglycosides have 4 ways in which they work:
1.They bind to a region in the accepter site
and this inhibits the binding of tRNA to the acceptor site,

  1. They also prevent the initiation complex from forming . –the initial stage when the 2 subunits combine around the first tRNA and the mRNA
    3.They cause the misreading of codons along the mRNA – so any proteins which are produced will not be functional
  2. they can cause the cell membrane to become permeable – which allows more aminoglycosides to accumulate inside the cell and increase its ‘cidal ‘ effects.

( Prevent formation of initiation complex
Inhibit binding of tRNA to A-site
Cause misreading of the codons (dysfunctional proteins)
Increase bacterial membrane permeability)